Demographics, Treatment Patterns, Safety, and Real-World Effectiveness in Patients ≥70 Years of Age with Chronic Lymphocytic Leukemia Receiving Bendamustine with or without Rituximab

被引：0
|
作者：
Kolibaba, Kathryn S. [1 ]
Joshi, Avani D. [2 ]
Sterchele, James A. [3 ]
Forsyth, Michael [2 ]
Alwon, Erin [2 ]
Beygi, Hooman [3 ]
Kennealey, Gerard T. [3 ]
机构：
[1] NW Canc Specialists, Vancouver, WA USA
[2] US Oncol, The Woodlands, TX USA
[3] Cephalon Inc, Frazer, PA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1674 / 1674
页数：1
相关论文
共 50 条
  • [41] Real-world effectiveness and safety of tixagevimab/cilgavimab lower dosage regimen in pre-exposure prophylaxis in patients undergoing treatment for chronic lymphocytic leukemia
    Simkovic, Martin
    Ecsiova, Dominika
    Vodarek, Pavel
    Maly, Josef
    Smolej, Lukas
    Rozsivalova, Petra
    LEUKEMIA & LYMPHOMA, 2023, 64 : S173 - S174
  • [42] Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
    Spacek, Martin
    Smolej, Lukas
    Simkovic, Martin
    Nekvindova, Lucie
    Kristkova, Zlatuse
    Brychtova, Yvona
    Panovska, Anna
    Maslejova, Stanislava
    Bezdekova, Lucie
    Ecsiova, Dominika
    Vodarek, Pavel
    Zuchnicka, Jana
    Mihalyova, Jana
    Urbanova, Renata
    Turcsanyi, Peter
    Lysak, Daniel
    Novak, Jan
    Brejcha, Martin
    Likarova, Tereza
    Vodicka, Prokop
    Baranova, Jana
    Trneny, Marek
    Doubek, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (01) : 40 - 47
  • [43] Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario
    Seung, Soo Jin
    Hurry, Manjusha
    Hassan, Shazia
    Elnoursi, Ashlie
    Scheider, Krystin A. B.
    Wagner, Dennis
    Edwin, Jonathan J.
    Aw, Andrew T. W.
    CURRENT ONCOLOGY, 2021, 28 (06) : 4832 - 4844
  • [44] Real-World Effectiveness of Frontline Treatments Among Patients with Chronic Lymphocytic Leukemia: Results from ConcertAI
    Roeker, Lindsey E.
    Burke, John M.
    Rhodes, Joanna M.
    Emechebe, Nnadozie
    Jawaid, Dureshahwar
    Manzoor, Beenish S.
    Jensen, Christopher E.
    Ryland, Lindsay
    Liu, Yangyang
    Marx, Steve E.
    Sinai, Wendy
    Roser, Jordan
    Shadman, Mazyar
    CANCERS, 2025, 17 (05)
  • [45] ECONOMIC EVALUATION OF BENDAMUSTINE PLUS RITUXIMAB IN THE FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Lachaine, J.
    Kouroukis, C. T.
    VALUE IN HEALTH, 2016, 19 (03) : A248 - A248
  • [46] Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/ Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study
    Ferra, Christelle
    Terol, Maria Jose
    Marquet Palomanes, Juan
    Ramirez Payer, Angel
    Moreno, Carol
    Osorio, Santiago
    De la Cruz, Fatima
    Garcia-Marco, Jose A.
    Ortiz, Macarena
    Rios Herranz, Eduardo
    Magnano, Laura
    Iraheta, Sandra
    Manuel Puerta, Jose
    de la Serna, Javier
    Smucler, Alicia
    Maria Arguinano, Jose
    Loscertales, Javier
    Muina, Begona
    Fernandez, Ruben
    Garcia, Tomas
    Marquez, Jose A.
    Muntanola Prat, Ana
    Perez Persona, Ernesto
    Yanez, Lucrecia
    Perez-Encinas, Manuel
    Gonzalez Diaz, Marcos
    Caballero, Gonzalo
    Angeles Andreu, Maria
    Andreu, Rafael
    Ruiz-Zorrilla, Ana
    Moreno, Diana
    Baltasar, Patricia
    BLOOD, 2022, 140 : 9908 - 9910
  • [47] Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen
    Schenkel, Brad
    Ellis, Lorie
    Korrer, Stephanie
    Byfield, Stacey DaCosta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [48] Real-World Dosing Patterns and Outcomes Among Patients With Chronic Lymphocytic Leukemia With or Without Dose Adjustment of First-Line Ibrutinib
    Rogers, Kerry
    Lu, Xiaoxiao
    Emond, Bruno
    Ding, Zhijie
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Mavani, Heena
    Qureshi, Zaina
    Ghosh, Nilanjan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
  • [49] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS RECEIVING TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER
    Weil, C.
    Chodick, G.
    Shalev, V
    Kan, I
    Afik, R.
    Cohen, R.
    Sail, K.
    VALUE IN HEALTH, 2019, 22 : S412 - S413
  • [50] Real-World Treatment Patterns, Adherence and Healthcare Resource Utilization for Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Among Veterans in the United States
    Yang, Keri
    Liu, Sizhu
    Tang, Boxiong
    Chanan-Khan, Asher
    BLOOD, 2021, 138
12345